BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vallée A, Lecarpentier Y, Guillevin R, Vallée JN. Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms. Neuromolecular Med 2018;20:174-204. [PMID: 29572723 DOI: 10.1007/s12017-018-8486-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Vallée A, Lecarpentier Y, Vallée JN. Interplay of Opposing Effects of the WNT/β-Catenin Pathway and PPARγ and Implications for SARS-CoV2 Treatment. Front Immunol 2021;12:666693. [PMID: 33927728 DOI: 10.3389/fimmu.2021.666693] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Vallée A, Lecarpentier Y, Vallée JN. Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway. Mol Psychiatry 2021. [PMID: 33837269 DOI: 10.1038/s41380-021-01086-1] [Reference Citation Analysis]
3 Vallée A, Lecarpentier Y, Guillevin R, Vallée JN. Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches. Int J Mol Sci 2018;19:E1212. [PMID: 29659554 DOI: 10.3390/ijms19041212] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
4 Vallée A, Lecarpentier Y, Vallée JN. Targeting the Canonical WNT/β-Catenin Pathway in Cancer Treatment Using Non-Steroidal Anti-Inflammatory Drugs. Cells 2019;8:E726. [PMID: 31311204 DOI: 10.3390/cells8070726] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 11.3] [Reference Citation Analysis]
5 Vallée A, Vallée JN, Lecarpentier Y. Potential role of cannabidiol in Parkinson's disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation. Aging (Albany NY) 2021;13:10796-813. [PMID: 33848261 DOI: 10.18632/aging.202951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Vallée A, Lecarpentier Y, Vallée JN. Curcumin: a therapeutic strategy in cancers by inhibiting the canonical WNT/β-catenin pathway. J Exp Clin Cancer Res 2019;38:323. [PMID: 31331376 DOI: 10.1186/s13046-019-1320-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
7 Bellei B, Picardo M. Premature cell senescence in human skin: Dual face in chronic acquired pigmentary disorders. Ageing Res Rev 2020;57:100981. [PMID: 31733332 DOI: 10.1016/j.arr.2019.100981] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
8 Vallée A, Lecarpentier Y, Guillevin R, Vallée JN. The influence of circadian rhythms and aerobic glycolysis in autism spectrum disorder. Transl Psychiatry 2020;10:400. [PMID: 33199680 DOI: 10.1038/s41398-020-01086-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Vallée A, Vallée JN, Lecarpentier Y. Parkinson's Disease: Potential Actions of Lithium by Targeting the WNT/β-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway. Cells 2021;10:230. [PMID: 33503974 DOI: 10.3390/cells10020230] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
10 Vallée A, Lecarpentier Y, Vallée JN. Opposed Interplay between IDH1 Mutations and the WNT/β-Catenin Pathway: Added Information for Glioma Classification. Biomedicines 2021;9:619. [PMID: 34070746 DOI: 10.3390/biomedicines9060619] [Reference Citation Analysis]
11 Vallée A, Vallée JN, Lecarpentier Y. Metabolic reprogramming in atherosclerosis: Opposed interplay between the canonical WNT/β-catenin pathway and PPARγ. J Mol Cell Cardiol 2019;133:36-46. [PMID: 31153873 DOI: 10.1016/j.yjmcc.2019.05.024] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
12 Vallée A, Lecarpentier Y, Vallée JN. The Key Role of the WNT/β-Catenin Pathway in Metabolic Reprogramming in Cancers under Normoxic Conditions. Cancers (Basel) 2021;13:5557. [PMID: 34771718 DOI: 10.3390/cancers13215557] [Reference Citation Analysis]
13 Tabak S, Schreiber-Avissar S, Beit-Yannai E. Trabecular meshwork's collagen network formation is inhibited by non-pigmented ciliary epithelium-derived extracellular vesicles. J Cell Mol Med 2021;25:3339-47. [PMID: 33644975 DOI: 10.1111/jcmm.16408] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Blasco H, Lanznaster D, Veyrat-Durebex C, Hergesheimer R, Vourch P, Maillot F, Andres CR, Pradat PF, Corcia P. Understanding and managing metabolic dysfunction in Amyotrophic Lateral Sclerosis. Expert Rev Neurother 2020;20:907-19. [PMID: 32583696 DOI: 10.1080/14737175.2020.1788389] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
15 Vallée A, Lecarpentier Y, Vallée JN. Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma. Int J Mol Sci 2021;22:3798. [PMID: 33917605 DOI: 10.3390/ijms22073798] [Reference Citation Analysis]
16 Vallée A, Lecarpentier Y, Guillevin R, Vallée JN. Circadian rhythms, Neuroinflammation and Oxidative Stress in the Story of Parkinson's Disease. Cells 2020;9:E314. [PMID: 32012898 DOI: 10.3390/cells9020314] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
17 Dutta A, Chattopadhyay H. A Brief on Biological Thermodynamics for Human Physiology. J Biomech Eng 2021;143:070802. [PMID: 33704420 DOI: 10.1115/1.4050458] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yan X, Hu Y, Wang B, Wang S, Zhang X. Metabolic Dysregulation Contributes to the Progression of Alzheimer's Disease. Front Neurosci 2020;14:530219. [PMID: 33250703 DOI: 10.3389/fnins.2020.530219] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
19 Vallée A, Lecarpentier Y. TGF-β in fibrosis by acting as a conductor for contractile properties of myofibroblasts. Cell Biosci 2019;9:98. [PMID: 31827764 DOI: 10.1186/s13578-019-0362-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 11.3] [Reference Citation Analysis]
20 Vallée A, Vallée JN, Lecarpentier Y. Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma. Biomedicines 2021;9:473. [PMID: 33925885 DOI: 10.3390/biomedicines9050473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Vallée A, Lecarpentier Y, Vallée R, Guillevin R, Vallée JN. Circadian Rhythms in Exudative Age-Related Macular Degeneration: The Key Role of the Canonical WNT/β-Catenin Pathway. Int J Mol Sci 2020;21:E820. [PMID: 32012797 DOI: 10.3390/ijms21030820] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Vallée A, Vallée JN, Guillevin R, Lecarpentier Y. Riluzole: a therapeutic strategy in Alzheimer's disease by targeting the WNT/β-catenin pathway. Aging (Albany NY) 2020;12:3095-113. [PMID: 32035419 DOI: 10.18632/aging.102830] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
23 Lu J, Zhang T, Sun H, Wang S, Liu M. Protective effects of dioscin against cartilage destruction in a monosodium iodoacetate (MIA)-indcued osteoarthritis rat model. Biomedicine & Pharmacotherapy 2018;108:1029-38. [DOI: 10.1016/j.biopha.2018.09.075] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]